methylformamide has been researched along with icrf 193 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beere, HM; Chresta, CM; Hickman, JA | 1 |
1 other study(ies) available for methylformamide and icrf 193
| Article | Year |
|---|---|
Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Diketopiperazines; DNA Damage; Enzyme Inhibitors; Etoposide; Formamides; HL-60 Cells; Humans; Piperazines; Topoisomerase II Inhibitors | 1996 |